Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) per Share (Tables)

Earnings (Loss) per Share (Tables)

3 Months Ended

Mar. 31, 2023

The computation of EPS is as follows:


	Three months ended March 31,
	2023			2022
Numerator—basic and diluted:
Net loss	$	(20,349	)	$	(14,214	)

Denominator:
Weighted average common shares - basic common stock (1)		23,009,617			22,754,421
Weighted average common shares - diluted common stock (2)		23,009,617			22,754,421

Net loss per share - basic common stock	$	(0.88	)	$	(0.62	)
Net loss per share - diluted common stock (2)	$	(0.88	)	$	(0.62	)

Denominator calculation from basic to diluted:
Weighted average common shares - basic common stock (1)		23,009,617			22,754,421
Stock options and other dilutive awards		228,281			88,193
Weighted average common shares - diluted common stock		23,237,898			22,842,614
Shares excluded from diluted weighted average shares:
Stock options		286,861			380,890
Restricted stock units and restricted stock awards		491,406			577,242
Shares excluded from diluted weighted average shares		778,267			958,132

(1)

Unvested restricted stock units and restricted stock awards are not included as shares outstanding in the calculation of basic earnings per share. Vested restricted stock units and restricted stock awards are included in basic earnings per share if all vesting and performance criteria have been met. Performance-based restricted stock units and restricted stock awards are included in the number of shares used to calculate diluted earnings per share as long as all applicable performance criteria are met, and their effect is dilutive. Restricted stock awards are eligible to receive all dividends declared on the Company’s common shares during the vesting period; however, such dividends are not paid until the restrictions lapse.

(2)

Due to net losses for the three months ended March 31, 2023 and March 31, 2022, diluted loss per share is the same as basic.